<b>Conclusions</b>: This rare outlier case of oligometastatic prostate adenocarcinoma challenges traditional linear models of metastatic progression and clinical reliance on PSA as a marker for PCa detection and treatment in advanced cases. This evidence concerns the gene KLK3 and prostate adenocarcinoma.